Arca Biopharma | ABIO - Umsatzerlöse

Aktienkurs
41.56
Täglich Wechseln
2.65 6.81%
Monatlich
16.87%
Jährlich
236.25%
Q1 Prognose
37.74




Der Umsatz Veränderung Datum
Alterity Therapeutics Limited AUD 11.38K 10.23K 2022-12
Amgen USD 9.9B 340M 2025-12
Arca Biopharma 0 0 2025-03
Biogen USD 2.28B 250M 2025-12
Brainstorm Cell Therapeutics 0 0 2025-03
Bristol-Myers Squibb USD 12.5B 300M 2025-12
Capricor Therapeutics USD 11.13M 8.87M 2024-12
Cipla INR 75.18B 710M 2025-12
Clal Biotechnology ILS 3.41M 2M 2022-12
Compugen USD 67.33M 65.44M 2025-12
CSL USD 8.33B 4.79B 2025-12
Cytokinetics USD 17.76M 15.83M 2025-12
Daiichi Sankyo JPY 558.11B 57.35B 2025-12
Gilead Sciences USD 7.93B 130M 2025-12
GlaxoSmithKline GBP 8.62B 73M 2025-12
Grifols EUR 2.34B 33.3M 2026-03
Laboratory Of America USD 3.52B 40M 2025-12
Myriad Genetics USD 209.8M 4.1M 2025-12
Otsuka Holdings JPY 650.15B 12.17B 2025-12
Pfizer USD 17.58B 880M 2025-12
United Therapeutics USD 790.2M 9.3M 2025-12